365
Views
14
CrossRef citations to date
0
Altmetric
Research Articles

DNA binding, antibacterial, hemolytic and anticancer studies of some fluorescent emissive surfactant-ruthenium(II) complexes

ORCID Icon, ORCID Icon, , , &
Pages 2242-2256 | Received 03 Feb 2020, Accepted 18 Mar 2020, Published online: 15 Apr 2020
 

Abstract

Designing the effective metallodrugs with amphiphilic nature is an active approach for the biomedical applications such as chemotheraphy, bioimaging, drug carrier, etc. To elaborate this, some fluorescent emissive surfactant–ruthenium(II) complexes and its precursor ruthenium(II) complexes have been interacted with calf thymus DNA (CT–DNA) for understanding the biophysical impacts of head and tail parts of the metallosurfactants. Here, DNA binding studies were examined by UV–visible absorption, fluorescence, circular dichroism and viscosity measurements. The obtained results showed that surfactant–ruthenium(II) complexes effectively bind with CT–DNA through hydrophobic interactions dominated moderate intercalation, whereas precursor ruthenium(II) complexes interact CT–DNA through electrostatic interactions dominated moderate intercalation. Also, increase of hydrophobic alkyl amine chain length as well as size of the head group in surfactant–ruthenium(II) complexes increased the binding affinity with CT–DNA, in which tail group played a dominant role. Further investigations of antibacterial, hemolytic and anticancer activities showed that desired biological activities could be obtained by tuning the head and tail groups of the metallodrugs in near future.

Communicated by Ramaswamy H. Sarma

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

Dr. S. Nehru acknowledges DST-SERB (EEQ/2018/001402) and DST-PURSE(II) Starter grant by University of Madras for providing financial support. Dr. S. Veeralakshmi thank DST-Women Scientist Scheme-A (SR/WOS-A/CS-40/2018 (G)) for sanctioning financial grant.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.